E
Pharmadrug Inc. PHRX
CNSX
Recommendation
Prev Close
Volume
--
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

06/30/2025 03/31/2025 12/31/2024 09/30/2024 06/30/2024
Net Income -52.50K -69.80K 52.00K -132.70K -95.80K
Total Depreciation and Amortization 9.10K 8.80K 9.00K 9.20K 9.20K
Total Amortization of Deferred Charges -- -- -- -- --
Total Other Non-Cash Items 31.50K 25.10K -40.50K 91.30K 85.10K
Change in Net Operating Assets -40.70K 25.60K -19.50K 25.30K -148.10K
Cash from Operations -52.60K -10.40K 1.00K -7.00K -149.60K
Capital Expenditure -- -- -- -- --
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities -- -- -8.60K -- --
Cash from Investing -- -- -8.60K -- --
Total Debt Issued -- -- -- -- --
Total Debt Repaid -- -- -- -- --
Issuance of Common Stock -- -- -- -- 0.00
Repurchase of Common Stock -- -- -91.60K -- --
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities -- -- 87.20K -- --
Cash from Financing -- -- -3.20K -- 0.00
Foreign Exchange rate Adjustments -- -- -1.70K -- --
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash -52.60K -10.40K -12.40K -7.00K -149.60K